Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance

Immunology and Microbiology

• Prion 100%
• Multidrug Resistance 18%
• Regulatory Mechanism 13%
• Oxidative Stress 9%
• Cancer Cell 9%
• Phase Separation 9%
• Lipid Raft 9%
• Drug Resistance 4%
• Epigenetics 4%
• Amino Terminal Sequence 4%
• Apoptosis 4%
• Conformational Transition 4%
• Ligand Binding 4%
• Cell Stress 4%
• pH 4%
• Signal Transduction 4%
• Lipid Peroxidation 4%
• Adjuvant 4%
• Electric Potential 4%
• Glycolysis 4%
• Differentiation 4%
• Adaptation 4%
• Aptitude 4%

Medicine and Dentistry

• Melatonin 22%
• Multidrug Resistance 18%
• Regulatory Mechanism 13%
• Cancer Cell 9%
• Malignant Neoplasm 9%
• Hypoxia 9%
• Oxidative Stress 9%
• Tumor Microenvironment 9%
• Lipid Raft 9%
• Prion Protein 9%
• Metastatic Carcinoma 4%
• Protein 4%
• Signal Transduction 4%
• Lipid Peroxidation 4%
• Metastasis Potential 4%
• Programmed Cell Death 4%
• Adaptive Response 4%
• Drug Resistance 4%
• Amino Terminal Sequence 4%
• Epigenomics 4%
• Adenosine Triphosphate 4%
• Cell Stress 4%
• Glycolysis 4%
• Cancer Therapy 4%
• Ligand Binding 4%
• Adaptation 4%
• Chemotherapeutic Agent 4%
• Cancer Adjuvant Therapy 4%
• Therapeutic Procedure 4%
• Differentiation 4%
• Aptitude 4%
• Cancer 4%

Biochemistry, Genetics and Molecular Biology

• Melatonin 22%
• Multidrug Resistance 18%
• Regulatory Mechanism 13%
• Cancer Cell 9%
• Oxidative Stress 9%
• Lipid Raft 9%
• Phase Separation 9%
• Signal Transduction 4%
• N-Terminus 4%
• Isoform 4%
• Apoptosis 4%
• pH 4%
• Lipid Peroxidation 4%
• Adaptive Response 4%
• Electric Potential 4%
• Conformational Change 4%
• Cell Stress 4%
• Adaptation 4%
• Glycolysis 4%
• Drug Resistance 4%
• Protein 4%
• Aptitude 4%